Cargando…

Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

INTRODUCTION: This randomized, double-blind, placebo-controlled, phase 2a trial was conducted to evaluate the safety and immunogenicity of the ID93 + glucopyranosyl lipid adjuvant (GLA)-stable emulsion (SE) vaccine in human immunodeficiency virus (HIV)-negative, previously Bacillus Calmette–Guérin (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Yu Hwa, Kang, Young Ae, Park, Kwang Joo, Choi, Jae Chol, Cho, Kwan Goo, Ko, Da Yeon, Ahn, Jun Ho, Lee, Boram, Ahn, Eunsol, Woo, Yun Ju, Jung, Kwangsoo, Kim, Nan Yul, Reese, Valerie A., Larsen, Sasha E., Baldwin, Susan L., Reed, Steven G., Coler, Rhea N., Lee, Hyejon, Cho, Sang-Nae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173211/ https://www.ncbi.nlm.nih.gov/pubmed/37166567 http://dx.doi.org/10.1007/s40121-023-00806-0

Ejemplares similares

Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model
por: Kwon, Kee Woong, et al.
Publicado: (2019)

The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
por: Coler, Rhea N., et al.
Publicado: (2018)

Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations
por: Baldwin, Susan L., et al.
Publicado: (2022)

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model
por: Baldwin, Susan L., et al.
Publicado: (2021)

Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults
por: Sagawa, Zachary K., et al.
Publicado: (2023)

Stressed stability and protective efficacy of lead lyophilized formulations of ID93+GLA-SE tuberculosis vaccine
por: Archer, Michelle C., et al.
Publicado: (2023)

A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93
por: Orr, Mark T., et al.
Publicado: (2014)

Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis?
por: Larsen, Sasha E., et al.
Publicado: (2023)

The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for T(H)1 Induction
por: Cauwelaert, Natasha Dubois, et al.
Publicado: (2016)

It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity
por: Larsen, Sasha E., et al.
Publicado: (2022)

The Current Status of BCG Vaccination in Young Children in South Korea
por: Lee, Hyejon, et al.
Publicado: (2012)

The adjuvant GLA-AF enhances human intradermal vaccine responses
por: Carter, Darrick, et al.
Publicado: (2018)

An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis
por: Larsen, Sasha E., et al.
Publicado: (2023)

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE
por: Coler, Rhea N, et al.
Publicado: (2015)

Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models
por: Larsen, Sasha E., et al.
Publicado: (2021)

BCG Vaccination
Publicado: (1989)

BCG Vaccination
por: Miller, Russell
Publicado: (1953)

Loss of Lipid Virulence Factors Reduces the Efficacy of the BCG Vaccine
por: Tran, Vanessa, et al.
Publicado: (2016)

GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
por: Clegg, Christopher H., et al.
Publicado: (2014)

BCG vaccine in Korea
por: Joung, Sun Myung, et al.
Publicado: (2013)

Clinical and immunological evaluation after BCG-id vaccine in leprosy patients in a 5-year follow-up study
por: Zenha, Erika Muller Ramalho, et al.
Publicado: (2012)

Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy
por: Fox, Christopher B., et al.
Publicado: (2012)

BCGΔBCG1419c increased memory CD8(+) T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis
por: Kwon, Kee Woong, et al.
Publicado: (2022)

Editorial: Beyond Th1: Novel concepts in tuberculosis vaccine immunology
por: Dijkman, Karin, et al.
Publicado: (2022)

The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases
por: Baldwin, Susan L., et al.
Publicado: (2019)

BCG Vaccine: Tuberculosis—Cancer
por: Pimm, M. V.
Publicado: (1980)

Studies on Dried BCG Vaccine
por: Cowles, Philip B.
Publicado: (1953)

B.C.G. Vaccine
por: Thakkar, K. V.
Publicado: (1949)

Observation on BCG Vaccination of Nurses
por: Kannivelu, P. D.
Publicado: (1954)

Protective Value of BCG Vaccination
Publicado: (1950)

Controversy over BCG Vaccination
Publicado: (1952)

Controversy over BCG Vaccination
Publicado: (1952)

B.C.G. Vaccination
por: Gemmill, J. S.
Publicado: (1951)

BCG Vaccine—The Road Not Taken
por: Dow, Coad Thomas, et al.
Publicado: (2022)

BCG Vaccination and Tuberculosis in Japan
por: Rahman, Mahbubur, et al.
Publicado: (2007)

BCG Vaccination Induces Different Cytokine Profiles Following Infant BCG Vaccination in the UK and Malawi
por: Lalor, Maeve K., et al.
Publicado: (2011)

PO and ID BCG vaccination in humans induce distinct mucosal and systemic immune responses and CD4+ T cell transcriptomal molecular signatures
por: Hoft, DF, et al.
Publicado: (2017)

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
por: Arias, Mauricio A., et al.
Publicado: (2012)

Severe Osteomyelitis as a Complication of Tokyo-172 BCG Vaccination
por: Kwon, Hyo Jin, et al.
Publicado: (2012)

Identification of MicroRNAs as Potential Blood-Based Biomarkers for Diagnosis and Therapeutic Monitoring of Active Tuberculosis
por: Kim, Junseong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ne6jn3fk01hliitrktbf5puj9h